S. Kurosawa

Y. Heike, S. Mori, Y. Takaue, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage

Y. Heike, K. Tobinai, A. Maeshima, 2013, Bone Marrow Transplantation.

Prognosis of core-binding factor acute myeloid leukemia after first relapse

Takuhiro Yamaguchi, I. Miura, S. Miyawaki, 2013 .

Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse

M. Shimoyama, Takuhiro Yamaguchi, N. Fujishima, 2010, Haematologica.

Decision analysis of up-front autologous hematopoietic stem cell transplantation in patients with peripheral T-cell lymphoma

S. Fuji, S. Kurosawa, T. Fukuda, 2019, Bone Marrow Transplantation.

Comparison of allogeneic hematopoietic cell transplantation and chemotherapy in elderly patients with non-M3 acute myelogenous leukemia in first complete remission.

Takuhiro Yamaguchi, Y. Nannya, I. Miura, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia: a single-center analysis of 47 patients

K. Tobinai, D. Maruyama, Takashi Watanabe, 2010, International journal of hematology.

Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia

J. Kanda, S. Kako, Y. Kanda, 2021, Blood advances.

Does an increased probability of graft‐vs‐host disease improve the survival of patients with adult T‐cell leukemia‐lymphoma? A simulation analysis using a Markov model

J. Kanda, T. Miyamoto, A. Utsunomiya, 2019, ADVANCES IN CELL AND GENE THERAPY.

N. Emi, I. Miura, S. Miyawaki, 2013, Bone Marrow Transplantation.

Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease.

S. Fuji, S. Kurosawa, T. Fukuda, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients.

M. Bar, M. Sorror, B. Sandmaier, 2019, Blood advances.

Characterization of Late Acute and Chronic Graft-Versus-Host Disease according to the 2014 National Institutes of Health Consensus Criteria in Japanese Patients.

S. Fuji, Y. Inoue, S. Kurosawa, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Characterization of readmission after allogeneic hematopoietic cell transplantation

S. Kurosawa, T. Fukuda, Y. Inamoto, 2021, Bone Marrow Transplantation.

Impact of T-Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen.

Y. Heike, S. Mori, Y. Takaue, 2007 .

Increased phosphatidylserine exposure on the erythrocyte membrane in patients with polycythaemia vera

H. Fujita, S. Nishimura, S. Kurosawa, 2011, British journal of haematology.

A decision analysis comparing unrelated bone marrow transplantation and cord blood transplantation in patients with aggressive adult T-cell leukemia-lymphoma

S. Yamasaki, A. Utsunomiya, I. Choi, 2019, International Journal of Hematology.

Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation.

S. Fuji, S. Kurosawa, T. Fukuda, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Significance Of Microcytosis In The Clinical Course Of Erythrocytosis

H. Fujita, S. Nishimura, S. Kurosawa, 2009 .

Idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia accompanied with cutaneous involvement and renal dysfunction.

M. Kojima, S. Kurosawa, J. Tomiyama, 2009, Japanese journal of clinical oncology.

Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia

K. Kawa, R. Suzuki, M. Kurokawa, 2013, Bone Marrow Transplantation.

Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia.

J. Kanda, S. Kako, Y. Kanda, 2018, Blood advances.

Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation.

H. Nakasone, K. Ohashi, H. Sakamaki, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey

Y. Kanda, Takuhiro Yamaguchi, M. Onizuka, 2018, Bone Marrow Transplantation.

Azacitidine as salvage therapy for relapsed acute myeloid leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation

I. Kawashima, S. Fuji, T. Ozawa, 2019, ADVANCES IN CELL AND GENE THERAPY.

Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation

T. Tanaka, Y. Tanaka, S. Fuji, 2016, Bone Marrow Transplantation.

Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia

S. Iida, T. Ueda, K. Inokuchi, 2013, Leukemia.

Comparison of valproate and levetiracetam for the prevention of busulfan-induced seizures in hematopoietic stem cell transplantation

H. Hashimoto, S. Kurosawa, T. Fukuda, 2019, International Journal of Hematology.

[Comparison of post-remission strategies in elderly patients with acute myeloid leukemia in first complete remission].

S. Kurosawa, 2011, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Severe immune-related complications early after allogeneic hematopoietic cell transplantation for nivolumab-pretreated lymphoma

S. Kurosawa, T. Fukuda, Y. Inamoto, 2018, Bone Marrow Transplantation.

Impact of hepatitis C virus infection on clinical outcome in recipients after allogeneic hematopoietic cell transplantation

H. Nakasone, R. Suzuki, H. Sakamaki, 2013, American journal of hematology.

Comparison of autologous hematopoietic cell transplantation and chemotherapy as postremission treatment in non-M3 acute myeloid leukemia in first complete remission.

M. Shimoyama, N. Fujishima, M. Hidaka, 2012, Clinical lymphoma, myeloma & leukemia.

Kinetics of neutrophil engraftment in allogeneic stem cell transplantation

S. Fuji, S. Kurosawa, T. Fukuda, 2019, Blood Cell Therapy.

Outcome of 93 patients with relapse or progression following allogeneic hematopoietic cell transplantation

Y. Heike, S. Mori, Y. Takaue, 2009, American journal of hematology.

The putative anti-leukemic effects of anti-thymocyte globulins in patients with CD7-positive acute myeloid leukemia

A. Tojo, S. Fuji, S. Kurosawa, 2018, Bone Marrow Transplantation.

Extramedullary Relapse of Acute Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.

S. Fuji, S. Kurosawa, T. Fukuda, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 cases

Y. Heike, S. Fuji, N. Hiramoto, 2013, International Journal of Hematology.

A higher number of infused CD34+ cells has a positive impact on the clinical outcome after related PBSC transplantation

Y. Heike, S. Fuji, Y. Inoue, 2014, Bone Marrow Transplantation.

Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations

J. Kanda, K. Inokuchi, Y. Fujiwara, 2016, Haematologica.

Association of CD204+ macrophages with poor outcomes of malignant lymphomas not in remission treated by allogeneic HCT

K. Izutsu, A. Maeshima, H. Taniguchi, 2019, European journal of haematology.

Patient-reported quality of life after allogeneic hematopoietic cell transplantation or chemotherapy for acute leukemia

M. Hino, N. Emi, C. Nakaseko, 2015, Bone Marrow Transplantation.

Impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation

S. Fuji, Kodai Kuriyama, Y. Inoue, 2016, International Journal of Hematology.

Beneficial impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation: focusing on difference between stem cell sources

I. Kawashima, S. Fuji, S. Kurosawa, 2018, Bone Marrow Transplantation.

A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F

K. Ohashi, M. Hidaka, S. Fuji, 2016, Bone Marrow Transplantation.

Use of mycophenolate mofetil and a calcineurin inhibitor in allogeneic hematopoietic stem-cell transplantation from HLA-matched siblings or unrelated volunteer donors: Japanese multicenter phase II trials

T. Matsui, M. Hino, Takuhiro Yamaguchi, 2017, International Journal of Hematology.

Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry

K. Kawa, R. Suzuki, M. Kurokawa, 2013, Bone Marrow Transplantation.

Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis

K. Inokuchi, Y. Fujiwara, M. Sakaguchi, 2018, Genes, chromosomes & cancer.

Full-length mutation search of the TP53 gene in acute myeloid leukemia has increased significance as a prognostic factor

K. Inokuchi, Y. Fujiwara, S. Kurosawa, 2017, Annals of Hematology.

High non-relapse mortality and low relapse incidence in gender-mismatched allogeneic hematopoietic stem cell transplantation from a parous female donor with a male child

N. Hiramoto, S. Kurosawa, T. Fukuda, 2017, Leukemia & lymphoma.

Chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challenges

K. Tobinai, S. Kurosawa, S. Makita, 2019, Drugs in context.

Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic Hematopoietic Cell Transplantation.

K. Tobinai, D. Maruyama, A. Maeshima, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immunogenicity of three versus four doses of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in allogeneic haematopoietic stem cell transplantation recipients: a multicentre, randomized controlled trial.

K. Oishi, S. Fuji, K. Koh, 2022, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Clinical impact of hyperglycemia on days 0–7 after allogeneic stem cell transplantation

T. Tanaka, Y. Tanaka, S. Fuji, 2017, Bone Marrow Transplantation.

Prognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remission

Takuhiro Yamaguchi, N. Emi, Masato Watanabe, 2012, Haematologica.

Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation

S. Owatari, A. Utsunomiya, K. Tobinai, 2017, Haematologica.

Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis

S. Yamasaki, A. Utsunomiya, I. Choi, 2018, Bone Marrow Transplantation.

Feasibility and usefulness of recommended screenings at long-term follow-up clinics for hematopoietic cell transplant survivors

Takuhiro Yamaguchi, T. Ueno, S. Fuji, 2021, Supportive Care in Cancer.

Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up

S. Fujiwara, Takuhiro Yamaguchi, S. Kato, 2021, Journal of Cancer Survivorship.

Current status and needs of long-term follow-up clinics for hematopoietic cell transplant survivors: results of a nationwide survey in Japan.

M. Hino, Y. Mori, Takehiko Mori, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.

Y. Kanda, Takuhiro Yamaguchi, K. Miyamura, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantation

T. Tanaka, Y. Tanaka, S. Fuji, 2017, Bone Marrow Transplantation.

Long-term follow-up system after allogeneic hematopoietic stem cell transplantation: a single-center feasibility study

Takuhiro Yamaguchi, S. Fuji, S. Kurosawa, 2014 .

Prognostic impact of pre-transplant quality of life and its post-transplant longitudinal change after allogeneic hematopoietic cell transplantation: a prospective study that administered SF-12 and EQ-5D.

Takuhiro Yamaguchi, S. Fuji, S. Kurosawa, 2021, Transplantation and cellular therapy.

[Management of late complications after allogeneic hematopoietic stem cell transplantation].

S. Kurosawa, T. Fukuda, 2013, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Incidence and predictors of recurrent sick leave in survivors who returned to work after allogeneic hematopoietic cell transplantation

S. Kako, Takuhiro Yamaguchi, N. Uoshima, 2022, Journal of Cancer Survivorship.

[Survivorship and long-term follow-up after allogeneic hematopoietic stem cell transplantation].

S. Kurosawa, 2021, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Long-term follow-up clinics after hematopoietic cell transplantation: its needs and challenges in Japan.

S. Kurosawa, 2017, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Cross-Sectional Patient Survey on the Need for a Long-Term Follow-up Program after Autologous Hematopoietic Cell Transplantation

K. Tobinai, D. Maruyama, S. Fuji, 2016 .

Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.

Y. Kanda, Takuhiro Yamaguchi, K. Miyamura, 2017, Biology of Blood and Marrow Transplantation.

Decision Analysis of Postremission Therapy in Cytogenetically Intermediate-Risk Acute Myeloid Leukemia: The Impact of FLT3 Internal Tandem Duplication, Nucleophosmin, and CCAAT/Enhancer Binding Protein Alpha.

J. Kanda, Takuhiro Yamaguchi, K. Inokuchi, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of donor type on volume of blood transfusions required after allogeneic hematopoietic cell transplantation

Takuhiro Yamaguchi, M. Takanashi, S. Kurosawa, 2021, International Journal of Hematology.

The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse

J. Kanda, Takuhiro Yamaguchi, K. Inokuchi, 2020, International Journal of Hematology.

Clinical Outcomes after Allogeneic Stem Cell Transplantation for Adult Lymphoblastic Lymphoma.

K. Tobinai, S. Fuji, Y. Inoue, 2016, Journal of clinical and experimental hematopathology : JCEH.

Clinical Utility of Wilms' Tumor 1 Monitoring in Patients with Myeloid Malignancy and Prior Allogeneic Hematopoietic Stem Cell Transplantation.

N. Katayama, S. Fuji, S. Kurosawa, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Usefulness of hematopoietic progenitor cell monitoring to predict autologous peripheral blood stem cell harvest timing: A single-center retrospective study.

K. Izutsu, D. Maruyama, W. Munakata, 2021, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for younger patients with acute myeloid leukemia: a registry-based study

M. Hirokawa, T. Kobayashi, Y. Atsuta, 2017, Bone Marrow Transplantation.

Novel and rapid enumeration method of peripheral blood stem cells using automated hematology analyzer

Y. Heike, S. Kurosawa, T. Fukuda, 2014, International journal of laboratory hematology.

Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B‐cell lymphoma associated with follicular lymphoma, or de novo diffuse large B‐cell lymphoma

Y. Matsuno, Y. Heike, K. Tobinai, 2012, American journal of hematology.

Prognostic significance of low pre-transplant skeletal muscle mass on survival outcomes in patients undergoing hematopoietic stem cell transplantation

S. Kurosawa, T. Fukuda, Y. Inamoto, 2019, International Journal of Hematology.

Characteristics of anaerobic bloodstream infections after allogeneic hematopoietic stem cell transplantation

S. Fuji, S. Kurosawa, T. Fukuda, 2017 .

Clinical and epidemiological features of Clostridium perfringens bacteremia: a review of 18 cases over 8 year-period in a tertiary care center in metropolitan Tokyo area in Japan.

H. Fujita, S. Nishimura, S. Kurosawa, 2010, Internal medicine.

Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia

J. Kanda, S. Kako, Y. Kanda, 2019, International Journal of Hematology.

Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia

J. Kanda, S. Kako, Y. Kanda, 2023, Cancer science.

Prognostic factors in patients with relapsed or refractory diffuse large B-cell lymphoma who underwent autologous stem-cell transplantation

K. Tobinai, D. Maruyama, H. Taniguchi, 2016 .

T-cell posttransplant lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

A. Maeshima, H. Taniguchi, S. Kurosawa, 2020, International Journal of Hematology.

Dynamic change of glycemic status during the early phase after allogeneic hematopoietic stem cell transplantation

S. Fuji, S. Kurosawa, T. Fukuda, 2015, Bone Marrow Transplantation.

Complex molecular genetic abnormalities involving three or more genetic mutations are important prognostic factors for acute myeloid leukemia

K. Inokuchi, Y. Fujiwara, E. Kawata, 2016, Leukemia.

Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.

Y. Kanda, Takuhiro Yamaguchi, K. Miyamura, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

K. Yagasaki, N. Emi, C. Nakaseko, 2022, Japanese Journal of Transplantation and Cellular Therapy.

Refractory Graft-Versus-Host Disease-Free, Relapse-Free Survival as an Accurate and Easy-to-Calculate Endpoint to Assess the Long-Term Transplant Success.

H. Nakasone, H. Wada, Y. Ishihara, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.